The company said Methscopolamine Bromide Tablets are AB rated to Pamine, a prescription medicine that is used as adjunctive therapy to treat peptic ulcers.
Pamine is marketed by Kenwood Therapeutics.
The product will hit the market in early 2012.
Breckenridge Pharmaceutical markets more than 70 products in a variety of dosage forms including Tablets, Capsules, Soft Gel Capsules, Liquids, Suspensions, and Powders.